Neurocrine Phase II insomnia results

NBIX said patients treated with its NBI-34060-MR non-benzodiazepine GABA(A) receptor agonist showed better sleep efficiency, the primary endpoint, than placebo (p<0.002) in a Phase II study of 47 adul...